That would be the preferred way. VA appointed by the Board triggers RCV being appointed under the SFA with McN very likely indeed to get the appointment although it is likely to be a jointly held commission between the AU and UK operations and perhaps even within the AU operations (particularly given the number of sites, offices etc to be dealt with).
Then there is also the matter of the Legal Receivers being appointed by the LSB. Given the size of the operations here locally, it would likely be a national firm that would be appointed so as to avoid the need for separate appointments being made in each state, or in relation to each of the individual entities. In this regard, there are probably only a dozen or so firms that would likely fit the bill, so it's probably a matter of also getting them sorted and /or co-ordinated.
So:
- Company
+ Board = VA
==>
+ Banks = Receivers
===>
+ Legal Practice = Legal Receivers being appointed by the relevant regulators.
- Forums
- ASX - By Stock
- Countdown to administration
SGH
sgh limited
Add to My Watchlist
1.10%
!
$51.40

That would be the preferred way. VA appointed by the Board...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$51.40 |
Change
-0.570(1.10%) |
Mkt cap ! $20.91B |
Open | High | Low | Value | Volume |
$52.74 | $52.74 | $51.24 | $18.10M | 351.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 245 | $51.20 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$51.46 | 1043 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 245 | 51.200 |
1 | 115 | 51.100 |
1 | 55 | 51.010 |
1 | 98 | 50.850 |
1 | 105 | 50.800 |
Price($) | Vol. | No. |
---|---|---|
51.460 | 600 | 1 |
51.590 | 445 | 1 |
52.050 | 500 | 1 |
52.470 | 258 | 1 |
52.700 | 95 | 1 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
SGH (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online